Jessica M. Latimer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jessica M. Latimer has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Diane M. Daubert
Department of Periodontics University of Washington School of Dentistry Seattle Washington USA
3 shared publications - William V. Giannobile
Department of Oral Medicine, Infection, and Immunity, School of Dental Medicine Harvard University Boston Massachusetts USA
3 shared publications - Georgios A. Kotsakis
Department of Oral Biology Rutgers School of Dental Medicine Newark New Jersey USA
2 shared publications - Tobias Fretwurst
Department of Oral & Craniomaxillofacial Surgery/Center for Dental Medicine University Medical Center Freiburg Freiburg Germany
2 shared publications ABCD study collaborators
1 shared publication- Abdusalam Alrmali
Department of Periodontics and Oral Medicine University of Michigan School of Dentistry Ann Arbor Michigan USA
1 shared publication
Latest Publications
- Open Access
- 30 March 2026
- Published by Wiley in Journal of Periodontology
Biomaterials for resolution of peri‐implantitis: Consensus report of Workgroup 2 of the IADR Implantology Research Group Best Evidence Consensus Symposium on Peri‐Implant Disease and Its Treatment
Background: Peri‐implantitis is a destructive disease affecting the tissues surrounding dental implants. Biomaterials may be applied during surgical treatment to reconstruct bony defects and support soft tissue healing. However, current evidence is unclear if these treatments increase the likelihood of peri‐implantitis resolution. Methods: A systematic review and meta‐analysis was performed on randomized controlled trials (RCTs) comparing surgical treatment with addition of reconstructive biomaterials (intervention) versus surgical treatment of peri‐implantitis alone (comparison) with follow‐up periods of at least 12 months. Resolution of peri‐implantitis, defined as a reduction of probing pocket depth (PPD) to ≤5 mm, absence bleeding on probing (BOP), and stable or decreasing radiographic defect level (RDL), was selected as the primary outcome. Secondary outcomes included RDL reduction, buccal mucosal recession (REC), and patient‐related outcome measures (PROMs). Risk of bias and quality of evidence were calculated using established guidelines. Results: Seven studies reporting on 402 patients with 405 implants met inclusion criteria. Wide variations in outcome reporting prevented the synthesis and quantitative comparison of peri‐implantitis disease resolution between intervention and comparison groups. Individual meta‐analyses showed a weighted mean difference (WMD) in PPD reduction of 0.28 mm [95% confidence interval (CI) ‐0.30, 0.86] and a relative risk (RR) for absence of BOP of 1.11 (95% CI 0.78, 1.59) for the inclusion of biomaterials (intervention) over access flap alone (comparison). For RDL reduction, a WMD of 1.08 mm (95% CI 0.41, 1.74) with significant heterogeneity (Q p ‐val: < 0.01, I 2 : 85%) and for REC, a WMD of ‐0.38 (95% CI −0.66, −0.11) was found, both in favor of the intervention. Analysis of the heterogeneity affecting RDL identified a positive effect on RDL when hydrogen peroxide but not rotary titanium brushes were used as an adjunct for implant surface debridement. Conclusion: Current evidence suggests that incorporating reconstructive biomaterials into surgical treatment may not definitively enhance the likelihood of peri‐implantitis disease resolution. However, this lack of effect may be due to other factors such as implant surface treatments which may also affect clinical outcomes. Overall, this work highlights the critical need for standardizing the reporting of composite outcomes for the resolution of peri‐implantitis disease and controlling for implant surface treatment effects when assessing reconstructive biomaterials. Plain language summary: Peri‐implantitis is a destructive disease affecting tissues around dental implants. We studied whether adding reconstructive biomaterials (i.e., biomaterials used to improve the likelihood of new bone formation or bone defect fill) to surgical treatments improves the clinical condition, meaning no further bone loss, probing pocket depths (PPD) ≤5 mm, and no bleeding on probing (BOP). We reviewed randomized controlled trials (RCTs) comparing surgery with biomaterials to surgery alone with at least 12 months of follow‐up. The main outcomes measured were PPD reduction, absence of BOP, and radiographic defect level (RDL). Secondary outcomes included RDL change, buccal mucosal recession (REC), and patient‐related outcomes (PROMs). Seven studies with 402 patients and 405 implants were analyzed. Due to variations in outcome reporting, it was challenging to compare the effectiveness of treatments. However, some individual analyses showed a small improvement in PPD and BOP with biomaterials. For RDL reduction, biomaterials showed better results, but with significant variability. REC also improved slightly with biomaterials. The analysis also suggested that using hydrogen peroxide, but not rotary titanium brushes, for implant cleaning could positively affect bone levels. The study concluded that adding biomaterials to surgical treatment does not definitively improve peri‐implantitis resolution, possibly due to other factors like implant surface treatments. This study emphasized the need for standardized reporting and considering these factors in future research.
- 30 March 2026
- Published by Wiley in Journal of Periodontology
Open AccessBiomaterials for resolution of peri‐implantitis: Consensus report of Workgroup 2 of the IADR Implantology Research Group Best Evidence Consensus Symposium on Peri‐Implant Disease and Its Treatment
Background: Peri‐implantitis is a destructive disease affecting the tissues surrounding dental implants. Biomaterials may be applied during surgical treatment to reconstruct bony defects and support soft tissue healing. However, current evidence is unclear if these treatments increase the likelihood of peri‐implantitis resolution. Methods: A systematic review and meta‐analysis was performed on randomized controlled trials (RCTs) comparing surgical treatment with addition of reconstructive biomaterials (intervention) versus surgical treatment of peri‐implantitis alone (comparison) with follow‐up periods of at least 12 months. Resolution of peri‐implantitis, defined as a reduction of probing pocket depth (PPD) to ≤5 mm, absence bleeding on probing (BOP), and stable or decreasing radiographic defect level (RDL), was selected as the primary outcome. Secondary outcomes included RDL reduction, buccal mucosal recession (REC), and patient‐related outcome measures (PROMs). Risk of bias and quality of evidence were calculated using established guidelines. Results: Seven studies reporting on 402 patients with 405 implants met inclusion criteria. Wide variations in outcome reporting prevented the synthesis and quantitative comparison of peri‐implantitis disease resolution between intervention and comparison groups. Individual meta‐analyses showed a weighted mean difference (WMD) in PPD reduction of 0.28 mm [95% confidence interval (CI) ‐0.30, 0.86] and a relative risk (RR) for absence of BOP of 1.11 (95% CI 0.78, 1.59) for the inclusion of biomaterials (intervention) over access flap alone (comparison). For RDL reduction, a WMD of 1.08 mm (95% CI 0.41, 1.74) with significant heterogeneity (Q p ‐val: < 0.01, I 2 : 85%) and for REC, a WMD of ‐0.38 (95% CI −0.66, −0.11) was found, both in favor of the intervention. Analysis of the heterogeneity affecting RDL identified a positive effect on RDL when hydrogen peroxide but not rotary titanium brushes were used as an adjunct for implant surface debridement. Conclusion: Current evidence suggests that incorporating reconstructive biomaterials into surgical treatment may not definitively enhance the likelihood of peri‐implantitis disease resolution. However, this lack of effect may be due to other factors such as implant surface treatments which may also affect clinical outcomes. Overall, this work highlights the critical need for standardizing the reporting of composite outcomes for the resolution of peri‐implantitis disease and controlling for implant surface treatment effects when assessing reconstructive biomaterials. Plain language summary: Peri‐implantitis is a destructive disease affecting tissues around dental implants. We studied whether adding reconstructive biomaterials (i.e., biomaterials used to improve the likelihood of new bone formation or bone defect fill) to surgical treatments improves the clinical condition, meaning no further bone loss, probing pocket depths (PPD) ≤5 mm, and no bleeding on probing (BOP). We reviewed randomized controlled trials (RCTs) comparing surgery with biomaterials to surgery alone with at least 12 months of follow‐up. The main outcomes measured were PPD reduction, absence of BOP, and radiographic defect level (RDL). Secondary outcomes included RDL change, buccal mucosal recession (REC), and patient‐related outcomes (PROMs). Seven studies with 402 patients and 405 implants were analyzed. Due to variations in outcome reporting, it was challenging to compare the effectiveness of treatments. However, some individual analyses showed a small improvement in PPD and BOP with biomaterials. For RDL reduction, biomaterials showed better results, but with significant variability. REC also improved slightly with biomaterials. The analysis also suggested that using hydrogen peroxide, but not rotary titanium brushes, for implant cleaning could positively affect bone levels. The study concluded that adding biomaterials to surgical treatment does not definitively improve peri‐implantitis resolution, possibly due to other factors like implant surface treatments. This study emphasized the need for standardized reporting and considering these factors in future research.
- 28 January 2026
- Published by Wiley in Journal of Periodontal Research
Biological Principles for Success in Alveolar Bone, Soft Tissue, and Periodontal Regeneration
Oral tissue regeneration involves the orchestration of known physiologic wound healing processes to synthesize single or composite tissues with functional, anatomical interfaces. Fundamental to oral tissue regeneration are the four main stages of wound healing: hemostasis, inflammation, proliferation, and remodeling. The oral cavity presents distinct challenges for regeneration due to its highly dynamic environment characterized by mechanical, microbiological, immunological, cellular, and biochemical factors that regulate cell‐matrix interactions. The incorporation of natural or synthetic matrices and biologic agents introduces additional considerations in regenerative therapy. The intrinsic capacity for regeneration in oral tissues is dictated by the tissue type and the defect characteristics. Accordingly, defect classification systems aid in treatment planning, guiding the selection of clinical techniques and regenerative biomaterials. This review outlines the fundamental biological principles required to predictably regenerate alveolar bone, gingiva, and the periodontium. Further, emerging technologies poised to advance personalized therapy will be explored, including customized, bioprinted scaffolds, immunoengineering strategies, and organ‐on‐chip platforms for disease modeling and therapeutic development.
- 28 January 2026
- Published by Wiley in Journal of Periodontal Research
Biological Principles for Success in Alveolar Bone, Soft Tissue, and Periodontal Regeneration
Oral tissue regeneration involves the orchestration of known physiologic wound healing processes to synthesize single or composite tissues with functional, anatomical interfaces. Fundamental to oral tissue regeneration are the four main stages of wound healing: hemostasis, inflammation, proliferation, and remodeling. The oral cavity presents distinct challenges for regeneration due to its highly dynamic environment characterized by mechanical, microbiological, immunological, cellular, and biochemical factors that regulate cell‐matrix interactions. The incorporation of natural or synthetic matrices and biologic agents introduces additional considerations in regenerative therapy. The intrinsic capacity for regeneration in oral tissues is dictated by the tissue type and the defect characteristics. Accordingly, defect classification systems aid in treatment planning, guiding the selection of clinical techniques and regenerative biomaterials. This review outlines the fundamental biological principles required to predictably regenerate alveolar bone, gingiva, and the periodontium. Further, emerging technologies poised to advance personalized therapy will be explored, including customized, bioprinted scaffolds, immunoengineering strategies, and organ‐on‐chip platforms for disease modeling and therapeutic development.
- 30 December 2025
- Published by Wiley in Journal of Periodontal Research
- Vol. 60 (12) , 1179-1180
In Tribute to Professor Harald Löe, Founding Editor of the Journal of Periodontal Research (1965)
- 30 December 2025
- Published by Wiley in Journal of Periodontal Research
- Vol. 60 (12) , 1179-1180
In Tribute to Professor Harald Löe, Founding Editor of the Journal of Periodontal Research (1965)
- Open Access
- 25 September 2025
- Published by Wiley in Journal of Esthetic and Restorative Dentistry
- Vol. 38 (4) , 709-718
Inverted T‐Shape Connective Tissue Graft for Interdental Papilla Reconstruction: A Clinical Case Series
Objective: To evaluate the clinical application and outcomes of the inverted T‐shape connective tissue graft (IT‐CTG) technique for reconstructing deficient interdental papillae in cases of advanced gingival recession, focusing on both quantitative and qualitative results in a consecutive case series. Clinical Considerations: The IT‐CTG technique was performed using a remotely mucoperiosteal tunnel approach, with the donor graft harvested in an inverted T configuration from the palate. Patient selection included five individuals with RT2 or RT3 recession and papilla loss in the esthetic zone, following defined inclusion and exclusion criteria. All surgical steps were standardized, including graft shape, the use of thin suture material, and a consistent postoperative care protocol. Quantitative outcomes such as papilla height gain and Jemt's papilla index improvement were assessed at 3, 6, and 12 months. Among five treated sites, complete papilla fill (Jemt index score 2) was achieved in two sites (both RT3 cases; 40%) after restorative procedures had been performed, and partial fill (Jemt index score 1–2, corresponding to 50%–75% improvement) was observed in the remaining three sites (RT2 cases; 60%). The mean Jemt's papilla index improved from a baseline of 0.2 to 1.8 in the final follow‐up. Acceptable esthetic outcomes and minimal morbidity were consistently noted across all patients. The addition of restorative procedures is expected to further enhance papilla fill and support creeping attachment over time. Conclusions: The inverted T‐shape connective tissue graft technique achieved acceptable papilla reconstruction, satisfactory esthetic outcomes, and minimal complications in this case series. While the results are promising, further controlled studies with larger sample sizes and longer follow‐up are necessary to confirm the efficacy and broader applicability of this approach. Clinical Significance: Loss of interdental papilla in advanced gingival recession presents a significant esthetic and functional challenge, often resulting in compromised smile esthetics and patient dissatisfaction. The IT‐CTG technique offers an innovative surgical solution for interdental papilla reconstruction, especially in cases where traditional approaches may be limited by poor vascularity and difficult access. By employing enhanced vascularization and a remotely tunneled approach, IT‐CTG may improve esthetic outcomes and restore papillary architecture in the anterior esthetic zone. This technique is particularly beneficial in cases of RT2 and RT3 recession with papilla loss, where achieving optimal fill in a single procedure is challenging. Integration of IT‐CTG into clinical practice expands the treatment options for clinicians managing complex mucogingival defects, though careful case selection and adjunctive restorative procedures may be required to support complete papilla regeneration and long‐term stability.
- 25 September 2025
- Published by Wiley in Journal of Esthetic and Restorative Dentistry
- Vol. 38 (4) , 709-718
Open AccessInverted T‐Shape Connective Tissue Graft for Interdental Papilla Reconstruction: A Clinical Case Series
Objective: To evaluate the clinical application and outcomes of the inverted T‐shape connective tissue graft (IT‐CTG) technique for reconstructing deficient interdental papillae in cases of advanced gingival recession, focusing on both quantitative and qualitative results in a consecutive case series. Clinical Considerations: The IT‐CTG technique was performed using a remotely mucoperiosteal tunnel approach, with the donor graft harvested in an inverted T configuration from the palate. Patient selection included five individuals with RT2 or RT3 recession and papilla loss in the esthetic zone, following defined inclusion and exclusion criteria. All surgical steps were standardized, including graft shape, the use of thin suture material, and a consistent postoperative care protocol. Quantitative outcomes such as papilla height gain and Jemt's papilla index improvement were assessed at 3, 6, and 12 months. Among five treated sites, complete papilla fill (Jemt index score 2) was achieved in two sites (both RT3 cases; 40%) after restorative procedures had been performed, and partial fill (Jemt index score 1–2, corresponding to 50%–75% improvement) was observed in the remaining three sites (RT2 cases; 60%). The mean Jemt's papilla index improved from a baseline of 0.2 to 1.8 in the final follow‐up. Acceptable esthetic outcomes and minimal morbidity were consistently noted across all patients. The addition of restorative procedures is expected to further enhance papilla fill and support creeping attachment over time. Conclusions: The inverted T‐shape connective tissue graft technique achieved acceptable papilla reconstruction, satisfactory esthetic outcomes, and minimal complications in this case series. While the results are promising, further controlled studies with larger sample sizes and longer follow‐up are necessary to confirm the efficacy and broader applicability of this approach. Clinical Significance: Loss of interdental papilla in advanced gingival recession presents a significant esthetic and functional challenge, often resulting in compromised smile esthetics and patient dissatisfaction. The IT‐CTG technique offers an innovative surgical solution for interdental papilla reconstruction, especially in cases where traditional approaches may be limited by poor vascularity and difficult access. By employing enhanced vascularization and a remotely tunneled approach, IT‐CTG may improve esthetic outcomes and restore papillary architecture in the anterior esthetic zone. This technique is particularly beneficial in cases of RT2 and RT3 recession with papilla loss, where achieving optimal fill in a single procedure is challenging. Integration of IT‐CTG into clinical practice expands the treatment options for clinicians managing complex mucogingival defects, though careful case selection and adjunctive restorative procedures may be required to support complete papilla regeneration and long‐term stability.
- 9 January 2025
- Published by Wiley in Clinical Oral Implants Research
- Vol. 36 (4) , 471-480
Abaloparatide Enhances Bone Regeneration in Extraction Socket Dental Implant Defects: An Experimental In Vivo Study
Objective: Abaloparatide (ABL) is a synthetic parathyroid hormone‐related protein analog developed as an anabolic drug to treat osteoporosis. ABL increases bone mineral density (BMD) of the long bones and spine; however, the influence of ABL on alveolar bone regeneration remains unknown. This study assessed the effects of systemic ABL administration on tooth extraction socket healing and dental implant osseointegration in a preclinical rodent model.Methods: Sprague‐Dawley rats received daily subcutaneous injection of ABL (25 μg/kg) or vehicle (VEH) at the time of maxillary first molar (M1) extraction surgery; animals underwent either: (1) unilateral M1 extraction followed by sacrifice at 10 or 42d or (2) bilateral M1 extraction followed by staged implant placement in osteotomies with standardized defects and sacrifice at 21 or 28d.Results: Micro‐computed tomography (micro‐CT) analysis demonstrated that ABL increased bone volume fraction (p = 0.004) and bone mineral density (BMD) (p = 0.006) of regenerated extraction sockets at 42d. Micro‐CT of the femur validated systemic effects of ABL, showing greater trabecular BMD after 6 (p < 0.01), 9 (p < 0.001), and 14 (p < 0.001) weeks of treatment. Histomorphometry confirmed a higher mineralized bone area with ABL treatment in extraction sockets at 42d (p = 0.03) and in the regenerated peri‐implant bone at 21d post‐implant placement (p = 0.01) compared to control.Conclusion: Systemic ABL administration enhances osteogenesis in extraction sockets prior to implant placement and accelerates peri‐implant bone formation in the early phase of healing in the present rodent model.
- 9 January 2025
- Published by Wiley in Clinical Oral Implants Research
- Vol. 36 (4) , 471-480
Abaloparatide Enhances Bone Regeneration in Extraction Socket Dental Implant Defects: An Experimental In Vivo Study
Objective: Abaloparatide (ABL) is a synthetic parathyroid hormone‐related protein analog developed as an anabolic drug to treat osteoporosis. ABL increases bone mineral density (BMD) of the long bones and spine; however, the influence of ABL on alveolar bone regeneration remains unknown. This study assessed the effects of systemic ABL administration on tooth extraction socket healing and dental implant osseointegration in a preclinical rodent model.Methods: Sprague‐Dawley rats received daily subcutaneous injection of ABL (25 μg/kg) or vehicle (VEH) at the time of maxillary first molar (M1) extraction surgery; animals underwent either: (1) unilateral M1 extraction followed by sacrifice at 10 or 42d or (2) bilateral M1 extraction followed by staged implant placement in osteotomies with standardized defects and sacrifice at 21 or 28d.Results: Micro‐computed tomography (micro‐CT) analysis demonstrated that ABL increased bone volume fraction (p = 0.004) and bone mineral density (BMD) (p = 0.006) of regenerated extraction sockets at 42d. Micro‐CT of the femur validated systemic effects of ABL, showing greater trabecular BMD after 6 (p < 0.01), 9 (p < 0.001), and 14 (p < 0.001) weeks of treatment. Histomorphometry confirmed a higher mineralized bone area with ABL treatment in extraction sockets at 42d (p = 0.03) and in the regenerated peri‐implant bone at 21d post‐implant placement (p = 0.01) compared to control.Conclusion: Systemic ABL administration enhances osteogenesis in extraction sockets prior to implant placement and accelerates peri‐implant bone formation in the early phase of healing in the present rodent model.
- 17 November 2024
- Published by Wiley in Clinical Advances in Periodontics
- Vol. 15 (4) , 322-328
The laterally closed coronally advanced flap: A case study
Background: Several methods have been described for treating deep Cairo Class RT1 recessions. Most involve relieving incisions, which cause scar tissue formation or use a tunneled approach. This report introduces a modified technique for treating a single deep recession beyond the mucogingival margin. The approach uses a laterally closed coronally advanced flap (LCAF) without relieving incisions, combined with a subepithelial connective tissue graft and enamel matrix derivative. Methods: A 28‐year‐old woman was referred to our periodontal practice for the treatment of a progressive deep Cairo Class I recession with hypersensitivity and limited access to hygiene measures. The root coverage procedure was performed using a modified LCAF, combined with a connective tissue graft from the palate and enamel matrix derivative. The case was followed for 6 months. Results: The healing process was uneventful. Six months after surgery, the root surfaces remained completely covered. Hypersensitivity resolved entirely, and there was only a slight formation of visible scar tissue. Conclusions: This modified technique of an LCAF is a feasible and effective method for treating single deep RT1 recessions. By avoiding visible relieving incisions, scar tissue formation is minimized. The preparation of an LCAF allows for adequate coronal advancement. Key points: As far as our knowledge, this is the first description of a laterally closed coronally advanced flap (LCAF) combining the advantage of a minimalized scarring root coverage with a simplified coronally advancement for recessions exceeding the mucogingival junction. This modified technique combines the advantages of a lateral closing with a CAF for covering deep class RT1 recessions. Meticulous handling of the delicate pedicles combined with a coronal advancement of at least 2 mm beyond the cemento‐enamel junction is the key factor for the successful adaption of this technique. Plain language summary: Deep gum recessions originating from traumatic hygiene measures can cause hypersensitivity and limit patients´ access to oral hygiene. Especially in deep recessions, the common surgical techniques have shortcomings due to a post‐surgical lack of keratinized gingiva or visible scar tissue formation. This case study shows the treatment of a 28‐year‐old woman´s deep recession on a mandibular front tooth introducing a modified surgical technique for covering deep gum recessions exceeding the area of the keratinized gingiva (so‐called deep Cairo RT1 recessions). This new technique uses a “laterally closed coronally advanced flap” (LCAF), which combines a curtain‐similar lateral closing of the flap pedicles with a coronal advancement to cover the recession without making cuts that can lead to scars. It is combined with a tissue graft from the patient's palate and a special protein to regenerate the periodontium. Six months after surgery, complete root coverage was achieved without remaining hypersensitivity and with restored access for oral hygiene measures. Minimal visible scar tissue formed. This case study demonstrates that the LCAF is a feasible technique for covering single deep gum recessions exceeding the keratinized area of the gingiva.
- 17 November 2024
- Published by Wiley in Clinical Advances in Periodontics
- Vol. 15 (4) , 322-328
The laterally closed coronally advanced flap: A case study
Background: Several methods have been described for treating deep Cairo Class RT1 recessions. Most involve relieving incisions, which cause scar tissue formation or use a tunneled approach. This report introduces a modified technique for treating a single deep recession beyond the mucogingival margin. The approach uses a laterally closed coronally advanced flap (LCAF) without relieving incisions, combined with a subepithelial connective tissue graft and enamel matrix derivative. Methods: A 28‐year‐old woman was referred to our periodontal practice for the treatment of a progressive deep Cairo Class I recession with hypersensitivity and limited access to hygiene measures. The root coverage procedure was performed using a modified LCAF, combined with a connective tissue graft from the palate and enamel matrix derivative. The case was followed for 6 months. Results: The healing process was uneventful. Six months after surgery, the root surfaces remained completely covered. Hypersensitivity resolved entirely, and there was only a slight formation of visible scar tissue. Conclusions: This modified technique of an LCAF is a feasible and effective method for treating single deep RT1 recessions. By avoiding visible relieving incisions, scar tissue formation is minimized. The preparation of an LCAF allows for adequate coronal advancement. Key points: As far as our knowledge, this is the first description of a laterally closed coronally advanced flap (LCAF) combining the advantage of a minimalized scarring root coverage with a simplified coronally advancement for recessions exceeding the mucogingival junction. This modified technique combines the advantages of a lateral closing with a CAF for covering deep class RT1 recessions. Meticulous handling of the delicate pedicles combined with a coronal advancement of at least 2 mm beyond the cemento‐enamel junction is the key factor for the successful adaption of this technique. Plain language summary: Deep gum recessions originating from traumatic hygiene measures can cause hypersensitivity and limit patients´ access to oral hygiene. Especially in deep recessions, the common surgical techniques have shortcomings due to a post‐surgical lack of keratinized gingiva or visible scar tissue formation. This case study shows the treatment of a 28‐year‐old woman´s deep recession on a mandibular front tooth introducing a modified surgical technique for covering deep gum recessions exceeding the area of the keratinized gingiva (so‐called deep Cairo RT1 recessions). This new technique uses a “laterally closed coronally advanced flap” (LCAF), which combines a curtain‐similar lateral closing of the flap pedicles with a coronal advancement to cover the recession without making cuts that can lead to scars. It is combined with a tissue graft from the patient's palate and a special protein to regenerate the periodontium. Six months after surgery, complete root coverage was achieved without remaining hypersensitivity and with restored access for oral hygiene measures. Minimal visible scar tissue formed. This case study demonstrates that the LCAF is a feasible technique for covering single deep gum recessions exceeding the keratinized area of the gingiva.
- 5 October 2024
- Published by Elsevier in The Journal of the American Dental Association
- Vol. 155 (11) , 954-962.e1
Physician-dentist dual referral model concept for coordinated bone anabolic therapy
- 5 October 2024
- Published by Elsevier in The Journal of the American Dental Association
- Vol. 155 (11) , 954-962.e1
Physician-dentist dual referral model concept for coordinated bone anabolic therapy
- Open Access
- 31 August 2024
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 8 (10) , ziae113
Healing sequelae following tooth extraction and dental implant placement in an aged, ovariectomy model
At present, a lack of consensus exists regarding the clinical impact of osteoporosis on alveolar bone metabolism during implant osseointegration. While limited preclinical and clinical evidence demonstrates a negative influence of osteoporosis on dental extraction socket healing, no preclinical studies offer data on the results of implant placement in 6-month-old, ovariectomized (OVX) Sprague–Dawley rats. This study aimed to investigate the outcomes of dental tooth extraction socket healing and implant placement in a rodent model of osteoporosis following daily vehicle (VEH) or abaloparatide (ABL) administration. Micro-CT and histologic analysis demonstrated signs of delayed wound healing, consistent with alveolar osteitis in extraction sockets following 42 days of healing in both the VEH and ABL groups. In a semiquantitative histological analysis, the OVX-ABL group demonstrated a tendency for improved socket regeneration with a three-fold greater rate for moderate socket healing when compared to the OVX-VEH group (43% versus 14%), however, this finding was not statistically significant (P=.11). No significant differences were observed between vehicle and test groups in terms of implant outcomes (BMD and BV/TV) at 14- and 21-days post-implant placement. Abaloparatide (ABL) significantly increased bone mineral density of the femoral shaft and intact maxillary alveolar bone sites in OVX animals, demonstrating the therapeutic potential for oral hard tissue regeneration. The present model involving estrogen-deficiency-induced bone loss demonstrated an impaired healing response to dental extraction and implant installation. Osteoporosis is a systemic disease that may negatively impact bone healing in the jaws. This study assesses extraction socket healing and dental implant placement in estrogen-deficient animals treated with a bone building drug, abaloparatide, compared to control.
- 31 August 2024
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 8 (10) , ziae113
Open AccessHealing sequelae following tooth extraction and dental implant placement in an aged, ovariectomy model
At present, a lack of consensus exists regarding the clinical impact of osteoporosis on alveolar bone metabolism during implant osseointegration. While limited preclinical and clinical evidence demonstrates a negative influence of osteoporosis on dental extraction socket healing, no preclinical studies offer data on the results of implant placement in 6-month-old, ovariectomized (OVX) Sprague–Dawley rats. This study aimed to investigate the outcomes of dental tooth extraction socket healing and implant placement in a rodent model of osteoporosis following daily vehicle (VEH) or abaloparatide (ABL) administration. Micro-CT and histologic analysis demonstrated signs of delayed wound healing, consistent with alveolar osteitis in extraction sockets following 42 days of healing in both the VEH and ABL groups. In a semiquantitative histological analysis, the OVX-ABL group demonstrated a tendency for improved socket regeneration with a three-fold greater rate for moderate socket healing when compared to the OVX-VEH group (43% versus 14%), however, this finding was not statistically significant (P=.11). No significant differences were observed between vehicle and test groups in terms of implant outcomes (BMD and BV/TV) at 14- and 21-days post-implant placement. Abaloparatide (ABL) significantly increased bone mineral density of the femoral shaft and intact maxillary alveolar bone sites in OVX animals, demonstrating the therapeutic potential for oral hard tissue regeneration. The present model involving estrogen-deficiency-induced bone loss demonstrated an impaired healing response to dental extraction and implant installation. Osteoporosis is a systemic disease that may negatively impact bone healing in the jaws. This study assesses extraction socket healing and dental implant placement in estrogen-deficient animals treated with a bone building drug, abaloparatide, compared to control.
- 5 November 2021
- Published by Wiley in Journal of Periodontology
- Vol. 93 (5) , 745-757
Clinical performance of hydrophilic, titanium‐zirconium dental implants in patients with well‐controlled and poorly controlled type 2 diabetes: One‐year results of a dual‐center cohort study
Background: This study assessed the clinical performance of hydrophilic dental implants in a patient cohort with type 2 diabetes mellitus (T2DM).Methods: Subjects with T2DM of ≥2‐years duration were allocated to either the well‐controlled (WC; HbA1c ≤ 7.0%,) or poorly‐controlled (PC; 7.5 < HbA1c < 10%) groups in a dual‐center, prospective cohort study. Each subject received a single, titanium‐zirconium (Ti‐Zr) dental implant with a chemically‐modified, hydrophilic (modSLA) surface in a posterior mandibular site. Postoperatively, subjects were followed at 1, 2, 4, 8, and 12‐week intervals. Post‐loading, subjects were followed at 3, 6, and 12‐months. Clinical and radiographic parameters of implant success, and dental patient‐reported outcomes were collected.Results: Twenty‐one dental patients (NWC = 11; NPC = 10; mean age: 66.8 ± 7.5 years) were enrolled and the 1‐year implant success rate was 100%. Peri‐implant bone levels were stable with 0.15 ± 0.06 mm mean marginal loss at 1 year without significant inter‐group differences (P = 0.79). Postoperative pain was minimal at 1‐week, and OHIP‐5 scores decreased significantly over time as compared with preoperative levels (P < 0.001) suggesting significant improvement in patient‐perceived oral health following implant therapy.Conclusions: Elevated HbA1c levels > 7.5% did not compromise 1‐year success rates, or oral health‐related quality of life in PC patients receiving modSLA, Ti‐Zr implants. Given that implant placement up to 10% HbA1c significantly enhanced oral health‐related quality of life without complications or morbidity, the safety and efficacy of implants to improve oral function in T2DM is supported, even without ideal glycemic control.
- 5 November 2021
- Published by Wiley in Journal of Periodontology
- Vol. 93 (5) , 745-757
Clinical performance of hydrophilic, titanium‐zirconium dental implants in patients with well‐controlled and poorly controlled type 2 diabetes: One‐year results of a dual‐center cohort study
Background: This study assessed the clinical performance of hydrophilic dental implants in a patient cohort with type 2 diabetes mellitus (T2DM).Methods: Subjects with T2DM of ≥2‐years duration were allocated to either the well‐controlled (WC; HbA1c ≤ 7.0%,) or poorly‐controlled (PC; 7.5 < HbA1c < 10%) groups in a dual‐center, prospective cohort study. Each subject received a single, titanium‐zirconium (Ti‐Zr) dental implant with a chemically‐modified, hydrophilic (modSLA) surface in a posterior mandibular site. Postoperatively, subjects were followed at 1, 2, 4, 8, and 12‐week intervals. Post‐loading, subjects were followed at 3, 6, and 12‐months. Clinical and radiographic parameters of implant success, and dental patient‐reported outcomes were collected.Results: Twenty‐one dental patients (NWC = 11; NPC = 10; mean age: 66.8 ± 7.5 years) were enrolled and the 1‐year implant success rate was 100%. Peri‐implant bone levels were stable with 0.15 ± 0.06 mm mean marginal loss at 1 year without significant inter‐group differences (P = 0.79). Postoperative pain was minimal at 1‐week, and OHIP‐5 scores decreased significantly over time as compared with preoperative levels (P < 0.001) suggesting significant improvement in patient‐perceived oral health following implant therapy.Conclusions: Elevated HbA1c levels > 7.5% did not compromise 1‐year success rates, or oral health‐related quality of life in PC patients receiving modSLA, Ti‐Zr implants. Given that implant placement up to 10% HbA1c significantly enhanced oral health‐related quality of life without complications or morbidity, the safety and efficacy of implants to improve oral function in T2DM is supported, even without ideal glycemic control.
- 15 July 2021
- Published by Wiley in Journal of Dental Education
- Vol. 86 (1) , 51-56
Integration of a new classification scheme for periodontal and peri‐implant diseases through blended learning
Purpose: In recent years, dental education has experienced a general shift toward an increased technology presence in education delivery and learning. This research examines the student‐perceived efficacy of a blended learning approach (mixture of online content and face‐to‐face instruction) in a predoctoral periodontics curriculum to teach a new periodontal classification scheme to dental students in clinical training.Methods: Participants were recruited from third‐ and fourth‐year predoctoral periodontal classes at the University of Washington School of Dentistry. Students were administered a live lecture introducing the new classification system and given access to an online module with built in case quizzes and interactive activities. Upon completing the module, students were given a post‐module survey to assess learning preferences, utilization of various learning methods, and student‐perceived efficacy of blended learning.Results: In a study group of 69 predoctoral dental students, the online module was the most preferred (52.2% ranked first) and utilized learning method for students (p < 0.001). Over 80% of students agreed or strongly agreed that they enjoyed using it and found it more effective than traditional lecture alone. Traditional lecture was preferred by 31.9% of students, and no students ranked the assigned reading as their first choice of learning method (p < 0.001).Conclusions: Our findings demonstrate higher student preference, utilization, and self‐perceived efficacy of blended learning as compared to traditional assigned readings and lectures – supporting blended learning as a promising educational approach for predoctoral dental education.
- 15 July 2021
- Published by Wiley in Journal of Dental Education
- Vol. 86 (1) , 51-56
Integration of a new classification scheme for periodontal and peri‐implant diseases through blended learning
Purpose: In recent years, dental education has experienced a general shift toward an increased technology presence in education delivery and learning. This research examines the student‐perceived efficacy of a blended learning approach (mixture of online content and face‐to‐face instruction) in a predoctoral periodontics curriculum to teach a new periodontal classification scheme to dental students in clinical training.Methods: Participants were recruited from third‐ and fourth‐year predoctoral periodontal classes at the University of Washington School of Dentistry. Students were administered a live lecture introducing the new classification system and given access to an online module with built in case quizzes and interactive activities. Upon completing the module, students were given a post‐module survey to assess learning preferences, utilization of various learning methods, and student‐perceived efficacy of blended learning.Results: In a study group of 69 predoctoral dental students, the online module was the most preferred (52.2% ranked first) and utilized learning method for students (p < 0.001). Over 80% of students agreed or strongly agreed that they enjoyed using it and found it more effective than traditional lecture alone. Traditional lecture was preferred by 31.9% of students, and no students ranked the assigned reading as their first choice of learning method (p < 0.001).Conclusions: Our findings demonstrate higher student preference, utilization, and self‐perceived efficacy of blended learning as compared to traditional assigned readings and lectures – supporting blended learning as a promising educational approach for predoctoral dental education.